文献速递临床免疫临床微生物

Presepsin在肝硬化合并细菌感染中的诊断与预后价值

Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection.
PubMed 文献 · Clin Chem Lab Med · 2020-10-23

该研究前瞻性纳入278例肝硬化患者的448次住院,评估Presepsin(PSP)对细菌感染(BI)的诊断和预后准确性。PSP诊断BI的AUC-ROC为0.69,低于C反应蛋白,与降钙素原相似;但Log10PSP是短期死亡的独立预测因子。

要点

  • PSP诊断肝硬化患者细菌感染的准确性较低,AUC-ROC仅0.69。
  • PSP对BI的诊断准确性低于C反应蛋白,与降钙素原相似。
  • Log10PSP是肝硬化患者短期死亡的独立预测因子。

核心结论

  • PSP对肝硬化患者细菌感染的诊断准确性低,但为短期死亡的独立预测因子,可能是终末期肝病系统性炎症的生物标志物。

研究设计与样本

  • 前瞻性队列研究,连续纳入2016年3月至2019年6月住院的成人肝硬化患者278例,共448次住院。

主要发现

  • 入院时细菌感染患病率为28.3%。
  • 全队列Log10PSP中位数(范围)为2.83(2.48-3.19)ng/L,感染患者显著高于非感染患者(p<0.001)。
  • 以2.87 ng/L为截断值,Log10PSP诊断BI的灵敏度0.66(95% CI 0.57-0.74)、特异度0.63(95% CI 0.57-0.68)、AUC-ROC 0.69(95% CI 0.63-0.73)。
  • PSP诊断准确性低于C反应蛋白(p=0.002),与降钙素原相似(p=0.18)。
  • 入院时合并BI者28天死亡风险更高(sHR 2.65;95% CI 1.49-4.70;p=0.001)。

关键数值与推荐

  • PSP截断值2.87 ng/L时,灵敏度0.66(95% CI 0.57-0.74),特异度0.63(95% CI 0.57-0.68),AUC-ROC 0.69(95% CI 0.63-0.73)。

临床怎么用

  • PSP不宜单独用于肝硬化患者细菌感染的早期诊断,但可辅助评估短期死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Serum biomarkers have suboptimal accuracy for the early diagnosis of bacterial infection (BI) in cirrhosis. The aim of the study was to evaluate the diagnostic and prognostic accuracy of presepsin (PSP) in a cohort of hospitalized patients with cirrhosis. METHODS: All adult cirrhotics admitted between 03.2016 and 06.2019 were consecutively evaluated. PSP was measured using chemiluminescent enzyme immunoassay, and its accuracy was compared with that of common biomarkers. RESULTS: A total of 278 cirrhotic patients for a total of 448 hospitalizations were prospectively collected. Prevalence of BI at admission was 28.3%. Median (range) Log10PSP in the whole cohort was 2.83 (2.48-3.19) ng/L, significantly higher in patients with BI than in patients without (p<0.001). For a cutoff value of 2.87 ng/L, Log10PSP showed sensitivity, specificity and AUC-ROC of 0.66 (95% CI 0.57-0.74), 0.63 (95% CI 0.57-0.68) and 0.69 (95% CI 0.63-0.73), lower than that of C-reactive protein (p=0.002), but similar to procalcitonin (p=0.18) Patients with BI at hospitalization had higher probability of 28-day mortality (sub-hazard ratio [sHR] 2.65;95% CI 1.49-4.70; p=0.001). At multivariate Cox's regression analysis, Log10PSP (sHR 2.4; 95% CI 1.22-4.82; p=0.01) together with age and severity of liver disease, was an independent predictor of short-term mortality. CONCLUSIONS: PSP shows low diagnostic accuracy for BI in cirrhosis, but it is an independent predictor of short-term mortality. PSP may be a biomarker of systemic inflammation, commonly seen in end-stage liver disease.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Ferrarese A, Frigo AC, Mion MM, et al. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. Clin Chem Lab Med. 2020. PMID: 33095752. doi:10.1515/cclm-2020-1212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。